| Literature DB >> 35893266 |
Felor Zargari1, Md Shiblur Rahaman2, Robab KazemPour3, Mahbobeh Hajirostamlou4.
Abstract
Infertility is a severe medical problem and is considered a serious global public health issue affecting a large proportion of humanity. Oxidative stress is one of the most crucial factors involved in infertility. Recent studies indicate that the overproduction of reactive oxygen species (ROS) or reactive nitrogen species (RNS) may cause damage to the male and female reproductive systems leading to infertility. Low amounts of ROS and RNS are essential for the normal functioning of the male and female reproductive systems, such as sperm motility, acrosome reaction, interactions with oocytes, ovulation, and the maturation of follicles. Environmental factors such as heavy metals can cause reproductive dysfunction in men and women through the overproduction of ROS and RNS. It is suggested that oxidative stress caused by arsenic is associated with male and female reproductive disorders such as through the alteration in sperm counts and motility, decreased sex hormones, dysfunction of the testis and ovary, as well as damage to the processes of spermatogenesis and oogenesis. This review paper highlights the relationship between arsenic-induced oxidative stress and the prevalence of infertility, with detailed explanations of potential underlying mechanisms.Entities:
Keywords: arsenic; female infertility; male infertility; oxidative stress; toxicity
Year: 2022 PMID: 35893266 PMCID: PMC9326564 DOI: 10.3390/jox12030016
Source DB: PubMed Journal: J Xenobiot ISSN: 2039-4705
Figure 1Effects of arsenic on the male and female reproductive systems.
Various negative effects of arsenic on the male and female reproductive systems.
| Negative Effects of Arsenic on the Male and Female Reproductive Systems | References |
|---|---|
| Reduction in the number of sperm (due to reduction in GSH and increased MDA) | [ |
| Increase in the levels of ROS in testes | [ |
| Alteration in hormone secretion (reduction in testosterone, FSH, LH) | [ |
| Disruption of spermatogenesis by inhibition of androgen receptor activity | [ |
| Interaction with the cysteine residues in DNA-binding domain (DBD) of steroid receptors inhibits their activity | [ |
| Reduction in testicular weight | [ |
| Alteration of some enzymes such as lactate dehydrogenase (LDH), acid phosphatase (ACP), γ-glutamyl transpeptidase (GGT) | [ |
| Reduction in sperm motility and viability | [ |
| Decrease in the expression level of CYP11A1, CYP17A1 | [ |
| Impaired sperm acrosome membrane protein 1 (SPACA1) and alteration in shape of sperm head | [ |
| Decrease in VDAC3 and disturbance of fertilization process | [ |
| Induction of inflammation in testes and increase in the production of inflammatory factors such as TNF-α, COX, NF-kB, caspase 3 | [ |
| Alteration of some regulator enzymes in steroidogenesis such as 3β-hydroxysteroid dehydrogenase (3-βHSD), 17β-hydroxysteroid dehydrogenase (17βHSD) due to low levels of gonadotropin | [ |
| Reduction in gonadotropin secretion due to alteration of the levels of some neurotransmitters (reduction in LH, FSH, estradiol) | [ |